Synovial sarcoma (SS) is a unique tumor that usually involves the large joints. Approximately 10% of these tumors develop in the neck, oropharynx, hypopharynx, and larynx . Despite the name, these tumors neither originate from synovium nor express synovial differentiation. SS typically presents in young adults (median age: 25 yr).The male-to-female ratio is 3: I. Symptoms are site-specific but tend to be nonspecific . SS typically appears as a solitary, painless mass, occasionally accompanied by dyspnea or hoarseness . The diameter of the lesion ranges from I to 12 em. The cut surface is yellow, firm, whorled , gritty, and friable; cyst formation with hemorrhage or mucoid material is often seen.
Histopathologically, SS is either monophasic (epithelial or spindle cells) or biphasic (epithelial and spindle cells).
The most common pattern is the monophasic spindle cell type, which is characterized by short, streaming fascicles of relatively uniform spindle cells with spindled nuclei and indistinct cell borders (figure I). In biphasic tumors , the epitheli al cells are arranged in solid nests, pseudoglands, or papillary structures (figure 2). Their shapes vary from cuboidal to tall columnar. Mitotic activity is easily identified, but it is not increased. Approximately one-third of all synovial sarcomas exhibit focal calcification. Poorly differentiated tumors are characterized by necrosis and increased mitotic figures. Either epithelial or mesenchymal mucin may be identified in each component of a biphasic tumor. Immunohistochemistry is necessary to confirm a diagnosis of SS. Both spindle and epithelial cells express low-and high-molecular-weight cytokeratins and epi-theli al membrane antigen, but only spindle cell s express vimentin and bcl-2.
SS has a unique balanced and reciprocal translocation: t(X;18)(p 11.2;q 11 .2).This finding is not seen in other neo-plasms. The histolo gic diffe renti al diagno sis is predicated on whether the tumor is biphasic or monophasic; it includes adenocarcinoma, spindle cell carcinoma, fibrosarcoma, malignant peripheral nerve sheath tumor, glomangiopericytoma (hem angiopericytoma), leiomyosarcom a, malignant melanom a, epithelioid sarcoma, and angiosarcoma.
Recurrence rates as high as 25% have been reported, usually within 2 years . Another 25 % of cases involve metasta sis, usually to the lung , bone, or lymph nodes . The 5-year survival rate is approximately 66%. A more favorable clinic al outcome is suggested by a young age at diagn osis, small tumor size « 5 ern), extensive calcification, and complete surgical removal. Therefore, meticulous attention to surgical margins and multimodality therap y (radiation and chemotherapy) will help achieve the best overall outcome. -certain people should exercise cautton before taking Ginkgo blJoba extr act . Those taking prescription anticoagulants should consult their physician before use. Discont inue use two weeks prior to any surgical procedure. 
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TINNITUS RELIEF IS UNDER THE ARCH
Crt-~J Tinnitus Formulas
"IT HAS BEEN MY EXPERIENCE in treating tinnitus with Arches Tinnitus Relief Formula th at 10% enjoy a complete reduction of symptoms. 10% experience no change, and 80% receive some degree of relief from their symptoms, varying by individual. I recommend Arches Tinnitus Relief Formula to many of my patients' and advise them to take two capsules in the morning and again in the evening and continue this dosage for 100 days before determining the degree of relief Arches Tinnitus Relief Formula will provide.'
Or. Seidma n is th e Medical orrecor of Arches and has a small financia l int erest in t he company .
